Showing results (861-870 of 888) with videos related to

Sort By:
Pageof 89
The Heart Surgery Forum|May 7, 2010
Consensus statement: minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypassR Clive Landis, John M Murkin, David A Stump, et al.
Molecular Oncology|February 17, 2023
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanised HGF knock-in miceMarie Fernandes, Brynna Hoggard, Philippe Jamme, et al.
Lancet (London, England)|June 11, 2019
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trialXavier Pivot, Gilles Romieu, Marc Debled, et al.
Disability and Rehabilitation|August 19, 2024
A qualitative study investigating the experiences of unmet social needs for children with cerebral palsy and their families: perspectives of parents and cliniciansKatarina Ostojic, Isra Karem, Simon Paget, et al.
The EMBO Journal|May 4, 2022
Host succinate inhibits influenza virus infection through succinylation and nuclear retention of the viral nucleoproteinAntoine Guillon, Deborah Brea-Diakite, Adeline Cezard, et al.
Cell Reports|March 5, 2020
Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid ProductionValentin Sencio, Adeline Barthelemy, Luciana P Tavares, et al.
BMJ Open|July 13, 2024
EPIC-CP pilot trial study protocol: a multicentre, randomised controlled trial investigating the feasibility and acceptability of social prescribing for Australian children with cerebral palsyKatarina Ostojic, Isra Karem, Simon Paget, et al.
Influenza and Other Respiratory Viruses|August 11, 2015
Epidemiological and virological characteristics of influenza B: results of the Global Influenza B StudySaverio Caini, Q Sue Huang, Meral A Ciblak, et al.
Cell Chemical Biology|November 13, 2019
Antitubercular Triazines: Optimization and Intrabacterial MetabolismXin Wang, Daigo Inoyama, Riccardo Russo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2018
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III TrialThierry André, Dewi Vernerey, Laurent Mineur, et al.
Pageof 89